116 related articles for article (PubMed ID: 38226993)
1. Mass Spectrometry-Based Proteomics Identifies Serpin B9 as a Key Protein in Promoting Bone Metastases in Lung Cancer.
Huang Y; Gong M; Chen H; Deng C; Zhu X; Lin J; Huang A; Xu Y; Tai Y; Song G; Xu H; Hu J; Feng H; Tang Q; Lu J; Wang J
Mol Cancer Res; 2024 Apr; 22(4):402-414. PubMed ID: 38226993
[TBL] [Abstract][Full Text] [Related]
2. A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP.
Mangan MS; Bird CH; Kaiserman D; Matthews AY; Hitchen C; Steer DL; Thompson PE; Bird PI
J Biol Chem; 2016 Feb; 291(7):3626-38. PubMed ID: 26670609
[TBL] [Abstract][Full Text] [Related]
3. Overview of serpin B9 and its roles in cancer (Review).
Wang WJ; Wang J; Ouyang C; Chen C; Xu XF; Ye XQ
Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278491
[TBL] [Abstract][Full Text] [Related]
4. Serpinb9 (Spi6)-deficient mice are impaired in dendritic cell-mediated antigen cross-presentation.
Rizzitelli A; Meuter S; Vega Ramos J; Bird CH; Mintern JD; Mangan MS; Villadangos J; Bird PI
Immunol Cell Biol; 2012 Oct; 90(9):841-51. PubMed ID: 22801574
[TBL] [Abstract][Full Text] [Related]
5. Serpinb9 is a marker of antigen cross-presenting dendritic cells.
Mangan MS; Vega-Ramos J; Joeckel LT; Mitchell AJ; Rizzitelli A; Roediger B; Kaiserman D; Weninger WW; Villadangos JA; Bird PI
Mol Immunol; 2017 Feb; 82():50-56. PubMed ID: 28024184
[TBL] [Abstract][Full Text] [Related]
6. Cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.
Karimpour M; Ravanbakhsh R; Maydanchi M; Rajabi A; Azizi F; Saber A
Biomed Pharmacother; 2021 Nov; 143():112190. PubMed ID: 34560543
[TBL] [Abstract][Full Text] [Related]
7. Expression of Serpin B9 as a Prognostic Factor of Colorectal Cancer.
Vycital O; Pitule P; Hosek P; Kriz T; Treska V; Liska V
Anticancer Res; 2019 Nov; 39(11):6063-6066. PubMed ID: 31704833
[TBL] [Abstract][Full Text] [Related]
8. Serpin B9 controls tumor cell killing by CAR T cells.
Kimman T; Slomp A; Martens A; Grabherr S; Li S; van Diest E; Meeldijk J; Kuball J; Minnema MC; Eldering E; Bovenschen N; Sebestyén Z; Peperzak V
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36931661
[TBL] [Abstract][Full Text] [Related]
9. Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy.
Jiang L; Wang YJ; Zhao J; Uehara M; Hou Q; Kasinath V; Ichimura T; Banouni N; Dai L; Li X; Greiner DL; Shultz LD; Zhang X; Sun ZJ; Curtin I; Vangos NE; Yeoh ZC; Geffken EA; Seo HS; Liu ZX; Heffron GJ; Shah K; Dhe-Paganon S; Abdi R
Cell; 2020 Nov; 183(5):1219-1233.e18. PubMed ID: 33242418
[TBL] [Abstract][Full Text] [Related]
10. Lung tumor cells inhibit bone mineralization and osteoblast activity.
Berent TE; Dorschner JM; Craig TA; Drake MT; Westendorf JJ; Kumar R
Biochem Biophys Res Commun; 2019 Nov; 519(3):566-571. PubMed ID: 31537378
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Functional proteomic analysis reveals that fungal immunomodulatory protein reduced expressions of heat shock proteins correlates to apoptosis in lung cancer cells.
Lin TY; Hua WJ; Yeh H; Tseng AJ
Phytomedicine; 2021 Jan; 80():153384. PubMed ID: 33113507
[TBL] [Abstract][Full Text] [Related]
13. Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer.
Yang XR; Pi C; Yu R; Fan XJ; Peng XX; Zhang XC; Chen ZH; Wu X; Shao Y; Wu YL; Zhou Q
Clin Exp Metastasis; 2021 Feb; 38(1):109-117. PubMed ID: 33231826
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of transforming growth factor-β release from tumor cells reduces their motility associated with epithelial-mesenchymal transition.
Ohshio Y; Teramoto K; Hashimoto M; Kitamura S; Hanaoka J; Kontani K
Oncol Rep; 2013 Aug; 30(2):1000-6. PubMed ID: 23715805
[TBL] [Abstract][Full Text] [Related]
15. PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis.
Catena R; Luis-Ravelo D; Antón I; Zandueta C; Salazar-Colocho P; Larzábal L; Calvo A; Lecanda F
Cancer Res; 2011 Jan; 71(1):164-74. PubMed ID: 21097719
[TBL] [Abstract][Full Text] [Related]
16. Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer.
Zhang C; Mao M; Guo X; Cui P; Zhang L; Xu Y; Li L; Han X; Peltzer K; Xiong S; Baklaushev VP; Wang X; Wang G
BMC Cancer; 2019 Mar; 19(1):238. PubMed ID: 30876473
[TBL] [Abstract][Full Text] [Related]
17. Proteomics approach to identify novel metastatic bone markers from the secretome of PC-3 prostate cancer cells.
Sung E; Kwon OK; Lee JM; Lee S
Electrophoresis; 2017 Oct; 38(20):2638-2645. PubMed ID: 28627741
[TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a novel web-based nomogram for patients with lung cancer with bone metastasis: A real-world analysis based on the SEER database.
Yin M; Guan S; Ding X; Zhuang R; Sun Z; Wang T; Zheng J; Li L; Gao X; Wei H; Ma J; Huang Q; Xiao J; Mo W
Front Oncol; 2022; 12():1075217. PubMed ID: 36568214
[TBL] [Abstract][Full Text] [Related]
19. TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling.
Fu L; Shi K; Wang J; Chen W; Shi D; Tian Y; Guo W; Yu W; Xiao X; Kang T; Wang S; Huang W; Deng W
Mol Cancer; 2014 Apr; 13():89. PubMed ID: 24766673
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-106a regulates autophagy-related cell death and EMT by targeting TP53INP1 in lung cancer with bone metastasis.
Han L; Huang Z; Liu Y; Ye L; Li D; Yao Z; Wang C; Zhang Y; Yang H; Tan Z; Tang J; Yang Z
Cell Death Dis; 2021 Oct; 12(11):1037. PubMed ID: 34718338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
